+91-8668442535

Sterile Injectables Market By Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Immunoglobulin, Vaccines, Peptide Hormones, Peptide Antibiotics, Blood Factors and Others), By Therapeutic Area (Cancer, Infectious Diseases, Diabetes, Cardiovascular Diseases, Neurological Diseases, Musculoskeletal Diseases and Others) - Growth, Future Prospects and Competitive Analysis, 2017 - 2025

The sterile injectables market is rising with the growing demand for biologics in order to treat numerous medical conditions with immediate and effective outcomes. The increased use of injectables has transformed medical treatments because higher-quality sterile injectables have reduced the possibility of contamination or infection.

The rising prevalence of cancer and chronic diseases aided the expansion of the sterile injectables market. Surging demand for biologics and the increasing trend of biosimilars act as major growth factors for the sterile injectables market. The increased use of generic injectables in pen-filled and pre-filled syringes in medical settings has also contributed to market growth. However, low-quality injectables products, inconsistent product launches, and the recall of substandard products were a few reasons behind the global issue of a major drug shortage, which further caused severe disadvantages to patients and healthcare providers. The high cost of automation in product development in order to manufacture improved sterile injectables and stringent regulatory guidelines for product approval has created challenges for the manufacturers, which in turn have restrained market growth. The sterile injectables market is expected to grow in the future due to a focus on a broadened product portfolio with pipeline products and restructuring through mergers and acquisitions of key players.

The scope of the research report titled "Sterile Injectables Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide investors, company executives, developers, and industry experts with detailed analysis of the market to take strategic initiatives and make business decisions regarding the prospects of the global sterile injectables market. The research report presents major market trends in the global sterile injectables market as well as the market size for the current and forecast periods. Global health concerns, increasing research expenditure, the utilization of advanced technology, and product innovation strongly boost the growth of the sterile injectables market.

This report contains an overview of the global sterile injectables market in terms of drug type, therapeutic areas, and geographical distribution. Based on drug types, the sterile injectables market is segmented into monoclonal antibodies, cytokines, insulin, immunoglobulin, vaccines, peptide hormones, peptide antibiotics, blood factors, and others. On the basis of therapeutic areas, the sterile injectables market has been classified as cancer, infectious diseases, diabetes, cardiovascular diseases, neurological diseases, musculoskeletal diseases, and others.

On the basis of geography, the sterile injectables market is classified into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, which are further categorized into major country-specific markets. The North American region consists of the data for the United States and Canada, whereas the United Kingdom, Germany, and the rest of Europe have been considered in the European region. Asia Pacific encompasses the information for China, Japan, India, and the rest of the Asia Pacific markets. Latin America is cross-sectioned into Brazil, Mexico, and other LATAM countries, and the Middle East and Africa are segmented into the GCC, South Africa, and other MEA countries. This research report provides market size and forecast for each mentioned geography from 2015 to 2025, as well as CAGRs for the forecast period from 2017 to 2025. Furthermore, the considered regional markets are further cross-sectioned on the basis of drug types and therapeutic areas.

This research study also provides insights in terms of market dynamics factors such as market drivers, restraints, and opportunities in the present and predicted markets for sterile injectables to deploy suitable business strategies. For a better understanding, the report includes comprehensive details on competitive assessment tools such as partnerships, major agreements, collaborations, mergers and acquisition activities, joint ventures, market attractiveness, and competitive landscape analysis by major players. Pfizer Inc., Mylan N.V., Baxter International Inc., Novartis AG, AstraZeneca plc., Amgen Limited, Merck & Co., Inc., Johnson & Johnson Services, Inc., Nichi-Iko Pharmaceutical Co., Sanofi, and Eli Lilly and Company are among the major players profiled in this report.

The sterile injectables market is classified on the basis of therapeutic area types, and the classes are as below:

  • Cancer
  • Infectious Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Neurological Diseases
  • Musculoskeletal Diseases
  • Others

Among all the therapeutic areas, cancer and infectious diseases are estimated to be the two most dominant segments. Sterile injectables have been shown to improve treatment outcomes in cancers such as lymphoma, cervical cancer, and testicular cancer. As per the statistics of the National Cancer Institute, there were around 14 million new cases of cancer in the year 2012, and with cancer being the world's leading cause of death, improved measures have been taken for prevention, diagnosis, and treatment procedures among public healthcare providers. Diabetes is considered to be responsible for around 1.5 million deaths in 2012, and such a high prevalence increases the demand for sterile injectables for treatment purposes. The growing trend of chronic ailments like cardiovascular diseases and neurological diseases has also boosted the growth of the sterile injectables market as a result of benefits such as faster recovery and fewer side effects. The rising prevalence of musculoskeletal disorders causes significant health issues among workers in the United States and Europe, where sterile injectables are used for long-term relief, acting as a key driver for the sterile injectables market's growth.

The sterile injectables market is categorized on the basis of drug types, and the categories are:

  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Immunoglobulin
  • Vaccines
  • Peptide Hormones
  • Peptide Antibiotics
  • Blood Factors
  • Other Drugs

The major share of sterile injectables is contributed by monoclonal antibodies, followed by vaccines and insulin, owing to increasing awareness among the public and growing application areas. The key driver of the monoclonal antibody injectables market is the increasing prevalence of cancer, respiratory diseases like asthma, infectious diseases, and autoimmune diseases like rheumatoid arthritis. Growing demand for monoclonal antibodies is on the rise due to proper dosing frequency for any treatment, potential therapeutics, and the targeting of specific antigens. Diabetes caused 1.6 million deaths worldwide in the year 2015; such a high prevalence of diabetes has increased the market for insulin injectables. Governments and healthcare organizations have taken various initiatives in order to develop an improved healthcare system, which drives the growth of the sterile injectables market, especially vaccines. Injectable vaccines are predicted to witness lucrative growth as a result of the development of innovative therapeutic vaccines for disease prevention and their increasing adoption among patients due to the offered convenience. Cytokine imbalance causes multiple diseases; therefore, injectable cytokine therapy significantly conquers multiple disease progression and therefore influences the growth of the sterile injectables market.

Geographically, the global sterile injectables market is cumulative for North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

North America is considered to be the leading region in terms of revenue in the global sterile injectables market since the U.S. is the main outsourcing destination for sterile injectables. North America is predicted to witness steady growth owing to its developed healthcare infrastructure, the growing prevalence of cancer and diabetes, and emerging health awareness among the public. The imbalance in the demand-supply equation has affected the sterile injectables market in North America, which has opened penetration opportunities for manufacturers from other developing countries. The growth opportunity of the sterile injectables market in North America is driven by the presence of major manufacturers and their market consolidation activities. However, regulatory guidelines and stringent FDA inspections sometimes act as barriers to new product launches, which in turn restrain the growth of the sterile injectables market. The sterile injectables market in Europe is driven by improved product formulation, increasing demand, and growing contract manufacturing options.

Asia Pacific is anticipated to witness the fastest growth during the upcoming years on account of developing healthcare infrastructures, emerging economies, and a gradual growth in health awareness among the public. Market penetration of Western pharmaceutical manufacturers, changing regulatory guidelines, new product innovation, commercialization, and contract manufacturing are expected to support significant growth of the sterile injectables market in the Asia Pacific region. Growing interest among Asian manufacturers in terms of manufacturing generic injectables is expected to positively influence the global sterile injectables market.

The regional classification of the global sterile injectables market is presented as follows:

  • North America (the United States and Canada)
  • Europe (the United Kingdom, Germany, and the rest of the European countries)
  • Asia Pacific (India, Japan, China, and the rest of the Asia Pacific countries)
  • Latin America (Mexico, Brazil, and the rest of LATAM countries)
  • Middle East and Africa (GCC, South Africa, and the rest of the MEA)

The sterile injectables market is categorized on the basis of drug types, and the categories are:

Monoclonal antibodies

  • Cytokines
  • Insulin
  • Immunoglobulin
  • Vaccines

 Peptide Hormones

 Peptide Antibiotics

  • Blood Factors
  • Other Drugs

The major share of sterile injectables is contributed by monoclonal antibodies, followed by vaccines and insulin, owing to increasing awareness among the public and growing application areas. The key driver of the monoclonal antibody injectables market is the increasing prevalence of cancer, respiratory diseases like asthma, infectious diseases, and autoimmune diseases like rheumatoid arthritis. Growing demand for monoclonal antibodies is on the rise due to proper dosing frequency for any treatment, potential therapeutics, and the targeting of specific antigens. Diabetes caused 1.6 million deaths worldwide in the year 2015; such a high prevalence of diabetes has increased the market for insulin injectables. Governments and healthcare organizations have taken various initiatives in order to develop an improved healthcare system, which drives the growth of the sterile injectables market, especially vaccines. Injectable vaccines are predicted to witness lucrative growth as a result of the development of innovative therapeutic vaccines for disease prevention and their increasing adoption among patients due to the offered convenience. Cytokine imbalance causes multiple diseases; therefore, injectable cytokine therapy significantly conquers multiple disease progression and therefore influences the growth of the sterile injectables market.

Frequently Asked Questions:

The market for Sterile Injectables is expected to reach US$ 324.1 Bn in 2025.

The Sterile Injectables market is expected to see significant CAGR growth over the coming years,at 7.1%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Amgen Limited.,AstraZeneca plc.,Baxter International, Inc.,Eli Lilly and Company,Johnson & Johnson Services, Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Nov 2017
Category:  Pharmaceuticals
Report ID:   58818
Report Format:   PDF
Pages:   120
Rating:    4.8 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support